DNA Damage Induced by Temozolomide Signals to both ATM and ATR: Role of the Mismatch Repair System

The DNA damage response: putting checkpoints in perspective

Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213

ATM and related protein kinases: safeguarding genome integrity

Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577

Cell cycle checkpoint signaling through the ATM and ATR kinases

Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966

Chk1 is an essential kinase that is regulated by Atr and required for the G 2 /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625

Regulation of the G2/M transition by p53

Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,584

DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2

Hirao, A., Kong, Y., Matsuoka, S., Wakeham, A. C., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,311

ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

Zhao, H., & Piwnica-Worms, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4129-4139.2001 · Cited by 1,091

Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation

Bulavin, D. V., Saito, S., Hollander, M. C., Sakaguchi, K., Anderson, C. W., Appella, E., & Fornace, A. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.23.6845 · Cited by 716

The cellular response to p53: the decision between life and death

Sionov, R. V., & Haupt, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1203130 · Cited by 608

Structure, Function, and Inhibition of O6-Alkylguanine-DNA Alkyltransferase

Pegg, A. E., Dolan, M. E., & Moschel, R. C. (1995) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)60879-x · Cited by 506

DNA damage and the balance between survival and death in cancer biology

Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189

DNA Mismatch Repair: Functions and Mechanisms

Iyer, R. R., Pluciennik, A., Burdett, V., & Modrich, P. L. (2005) · Chemical Reviews · doi:10.1021/cr0404794 · Cited by 935

DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis

Roos, W. P., & Kaina, B. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.01.007 · Cited by 879

ATM and ATR as therapeutic targets in cancer

Weber, A. M., & Ryan, A. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.001 · Cited by 676

Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions

Stupp, R., Hegi, M. E., Gilbert, M. R., & Chakravarti, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8554 · Cited by 531

Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage

Knizhnik, A. V., Roos, W. P., Nikolova, T., Quirós, S., Tomaszowski, K.-H., Christmann, M., & Kaina, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055665 · Cited by 286

Intranasal delivery of targeted polyfunctional gold–iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide

Sukumar, U. K., Bose, R. J., Malhotra, M., Babikir, H. A., Afjei, R., Robinson, E. R., Zeng, Y., Chang, E., Habte, F. G., Sinclair, R., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119342 · Cited by 265

Mouse Models of Colon Cancer

Taketo, M. M., & Edelmann, W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.049 · Cited by 257

Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress

Yan, S., Sorrell, M., & Berman, Z. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1666-4 · Cited by 247

O6-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistry

Christmann, M., Verbeek, B., Roos, W. P., & Kaina, B. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.06.002 · Cited by 242

Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy

Lin, C., Lee, C.-C., Shih, Y., Lin, T.-Y., Wang, S.-H., Lin, Y., & Shih, C.-M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.487 · Cited by 225

Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

Peasland, A., Wang, L.-Z., Rowling, E. J., Kyle, S., Chen, T., Hopkins, A. P., Cliby, W. A., Sarkaria, J. N., Beale, G., Edmondson, R. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.243 · Cited by 202

Targeting ATR in DNA damage response and cancer therapeutics

Fokas, E., Prevo, R., Hammond, E. M., Brunner, T. B., McKenna, W. G., & Muschel, R. J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.002 · Cited by 197

Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair

Goellner, E. M., Grimme, B., Brown, A. R., Lin, Y., Wang, X., Sugrue, K. F., Mitchell, L., Trivedi, R. N., Tang, J.-B., & Sobol, R. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3213 · Cited by 155

Effect of Chemotherapy-Induced DNA Repair on Oncolytic Herpes Simplex Viral Replication

Aghi, M. K., Rabkin, S. D., & Martuza, R. L. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj003 · Cited by 145

DNA repair in personalized brain cancer therapy with temozolomide and nitrosoureas

Kaina, B., & Christmann, M. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.04.007 · Cited by 147

Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response

Nishida, H., Tatewaki, N., Nakajima, Y., Magara, T., Ko, K. M., Hamamori, Y., & Konishi, T. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp593 · Cited by 133

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma

Yoshimoto, K., Mizoguchi, M., Hata, N., Murata, H., Hatae, R., Amano, T., Nakamizo, A., & Sasaki, T. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00186 · Cited by 126

FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51

Zhang, N., Wu, X.-J., Yang, L., Xiao, F., Zhang, H., Zhou, A., Huang, Z., & Huang, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0039 · Cited by 121

Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide

Eich, M., Roos, W. P., Nikolova, T., & Kaina, B. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0136 · Cited by 124

NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma

Weiß, T., Schneider, H., Silginer, M., Steinle, A., Pruschy, M. N., Polić, B., Weller, M., & Roth, P. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1766 · Cited by 116

Genotoxic therapy and resistance mechanism in gliomas

Lang, F., Liu, Y., Chou, F.-J., & Yang, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107922 · Cited by 116

Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention

Poon, S. L., McPherson, J. R., Tan, P. B. O., Teh, B. T., & Rozen, S. (2014) · Genome Medicine · doi:10.1186/gm541 · Cited by 115

Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O6-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs

Roos, W. P., Nikolova, T., Quirós, S., Naumann, S. C., Kiedron, O., Zdzienicka, M. Z., & Kaina, B. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.003 · Cited by 106

Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells

Short, S. C., Giampieri, S., Worku, M., Alcaide-German, M., Sioftanos, G., Bourne, S., Lio, K. I., Shaked-Rabi, M., & Martindale, C. A. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor010 · Cited by 103

Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53

Naumann, S. C., Roos, W. P., Jöst, E., Belohlavek, C., Lennerz, V., Schmidt, C., Christmann, M., & Kaina, B. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604856 · Cited by 101

Mismatch Repair-dependent Iterative Excision at Irreparable O6-Methylguanine Lesions in Human Nuclear Extracts

York, S. J., & Modrich, P. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603667200 · Cited by 98

Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy.

Rabik, C., Njoku, M., & Dolan, M. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.03.004 · Cited by 92

DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma

Meng, X., Duan, C., Pang, H., Chen, Q., Han, B. R., Zha, C., Dinislam, M., Wu, P., Li, Z., Zhao, S., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.067 · Cited by 93

DNA Damage Response and Growth Factor Signaling Pathways in Gliomagenesis and Therapeutic Resistance

Squatrito, M., & Holland, E. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1245 · Cited by 86

MicroRNA‐155 targets theSKIgene in human melanoma cell lines

Levati, L., Pagani, E., Romani, S., Castiglia, D., Piccinni, E., Covaciu, C., Caporaso, P., Bondanza, S., Antonetti, F. R., Bonmassar, E., et al. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00857.x · Cited by 85

Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells

Sultana, R., Abdel-Fatah, T. M. A., Perry, C., Moseley, P. M., Albarakati, N., mohan, V. C., Seedhouse, C., Chan, S. Y. T., & Madhusudan, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057098 · Cited by 87

miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A

Caporali, S., Amaro, A. A., Levati, L., Alvino, E., Lacal, P. M., Mastroeni, S., Ruffini, F., Bonmassar, L., Cappellini, G. C. A., Felli, N., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1238-4 · Cited by 82

AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition

Caporali, S., Levati, L., Starace, G., Ragone, G., Bonmassar, E., Alvino, E., & D’Atri, S. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.044743 · Cited by 80

Temozolomide induces autophagy via ATM-AMPK-ULK1 pathways in glioma

Zou, Y., Wang, Q., Li, B., Xie, B., & Wang, W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2151 · Cited by 83

Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide

Hingtgen, S., Ren, X., Terwilliger, E., Classon, M., Weissleder, R., & Shah, K. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0640 · Cited by 80

Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer

Curtin, N. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12244 · Cited by 78

Anthocyanins/anthocyanidins and colorectal cancer: What is behind the scenes?

Moraes, L. F. D. S., Sun, X., Pelúzio, M. D. C. G., & Zhu, M. J. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1357533 · Cited by 74

Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma

Han, B. R., Cai, J., Gao, W., Meng, X., Gao, F., Wu, P., Duan, C., Wang, R., Dinislam, M., Lin, L., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.056 · Cited by 74

DNA Structure and Integrity Checkpoints during the Cell Cycle and Their Role in Drug Targeting and Sensitivity of Tumor Cells to Anticancer Treatment

Składanowski, A., Bozko, P. M., & Sabisz, M. (2009) · Chemical Reviews · doi:10.1021/cr900026u · Cited by 74

Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor

Caporali, S., Alvino, E., Lacal, P. M., Levati, L., Giurato, G., Memoli, D., Caprini, E., Cappellini, G. C. A., & D’Atri, S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3594 · Cited by 71

ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells

Nadkarni, A., Shrivastav, M., Mladek, A. C., Schwingler, P. M., Grogan, P. T., Chen, J., & Sarkaria, J. N. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0979-0 · Cited by 70

O 6 -methylguanine-induced cell death involves exonuclease 1 as well as DNA mismatch recognition in vivo

Klapacz, J., Meira, L. B., Luchetti, D., Calvo, J. A., Bronson, R. T., Edelmann, W., & Samson, L. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811991106 · Cited by 64

Cytotoxic Effects of Temozolomide and Radiation are Additive- and Schedule-Dependent

Chalmers, A. J., Ruff, E. M., Martindale, C. A., Lovegrove, N., & Short, S. C. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1703 · Cited by 65

Molecular and Circulating Biomarkers in Patients with Glioblastoma

Senhaji, N., Houssaini, A. S., Lamrabet, S., Louati, S., & Bennis, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137474 · Cited by 60

Prospects for the Use of ATR Inhibitors to Treat Cancer

Wagner, J. M., & Kaufmann, S. H. (2010) · Pharmaceuticals · doi:10.3390/ph3051311 · Cited by 57

Pharmacologic and Chemical Adjuvants in Tumor Virotherapy

Alvarez-Breckenridge, C. A., Kaur, B., & Chiocca, E. A. (2009) · Chemical Reviews · doi:10.1021/cr900048k · Cited by 58

DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide

Jowsey, P. A., Williams, F. M., & Blain, P. G. (2008) · Toxicology · doi:10.1016/j.tox.2008.12.001 · Cited by 54

EFEMP1 induces γ-secretase/Notch-mediated temozolomide resistance in glioblastoma

Hiddingh, L., Tannous, B. A., Teng, J., Tops, B. B. J., Jeuken, J. W. M., Hulleman, E., Boots‐Sprenger, S., Vandertop, W. P., Noske, D. P., Kaspers, G. J. L., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1620 · Cited by 54

The Mre11/Rad50/Nbs1 complex interacts with the mismatch repair system and contributes to temozolomide-induced G2 arrest and cytotoxicity

Mirzoeva, O. K., Kawaguchi, T., & Pieper, R. O. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0183 · Cited by 52

Disparate roles of ATR and ATM in immunoglobulin class switch recombination and somatic hypermutation

Pan‐Hammarström, Q., Lähdesmäki, A., Zhao, Y., Du, L., Zhao, Z., Wen, S., Ruiz‐Pérez, V. L., Dunn‐Walters, D. K., Goodship, J. A., & Hammarström, L. L. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050595 · Cited by 58

The promise of DNA damage response inhibitors for the treatment of glioblastoma

Majd, N., Yap, T. A., Koul, D., Balasubramaniyan, V., Li, X., Khan, S., Gandy, K. S., Yung, W. K. A., & de Groot, J. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab015 · Cited by 53

Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence

Berte, N., Lokan, S., Eich, M., Kim, E. L., & Kaina, B. (2016) · Oncotarget · doi:10.18632/oncotarget.11972 · Cited by 50

Hypoxanthine phosphoribosyl transferase 1 metabolizes temozolomide to activate AMPK for driving chemoresistance of glioblastomas

Yin, J., Wang, X., Ge, X. Q., Ding, F., Shi, Z., Ge, Z., Huang, G., Zhao, N., Chen, D., Zhang, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41663-2 · Cited by 48

Inhibition of glioblastoma cell proliferation, invasion, and mechanism of action of a novel hydroxamic acid hybrid molecule

Zhang, I., Beus, M., Stochaj, U., Le, P. U., Zorc, B., Rajić, Z., Petrecca, K., & Maysinger, D. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0103-0 · Cited by 48

HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines

Kim, J., Kim, J. Y., Kim, J., Kim, S., Chung, H., & Park, C. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.16 · Cited by 43

O6-Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling network activation

Noonan, E. M., Shah, D., Yaffe, M. B., Lauffenburger, D. A., & Samson, L. D. (2012) · Integrative Biology · doi:10.1039/c2ib20091k · Cited by 41

Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways

Sampson, V. B., Vetter, N. S., Kamara, D. F., Collier, A. B., Gresh, R. C., & Kolb, E. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142704 · Cited by 42

The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer

Pang, Y. K., Chen, X., Ji, T., Cheng, M., Wang, R., Zhang, C., Liu, M., Zhang, J., & Zhong, C. (2023) · Cancers · doi:10.3390/cancers15082228 · Cited by 46

Synergistic effect of temozolomide and thymoquinone on human glioblastoma multiforme cell line (U87MG)

Pazhouhi, M., Sariri, R., Khazaei, M. R., Moradi, M., & Khazaei, M. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.187241 · Cited by 40

DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies

Rominiyi, O., & Collis, S. J. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13020 · Cited by 44

Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?

Vilar, J. B., Christmann, M., & Tomicic, M. T. (2022) · Cancers · doi:10.3390/cancers14102416 · Cited by 43

Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition

Kedar, P. S., Stefanick, D. F., Horton, J. K., & Wilson, S. H. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.07.006 · Cited by 45

Human MutL-complexes monitor homologous recombination independently of mismatch repair

Siehler, S. Y., Schrauder, M. G., Gerischer, U. C., Cantor, S. B., Marra, G., & Wiesmüller, L. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.10.011 · Cited by 41

MLH1- and ATM-dependent MAPK Signaling Is Activated through c-Abl in Response to the Alkylator N-Methyl-N′-nitro-N′-nitrosoguanidine

Kim, W.-J., Rajasekaran, B., & Brown, K. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701451200 · Cited by 40

Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma

Castiglia, D., Bernardini, S., Alvino, E., Pagani, E., Luca, N. D., Falcinelli, S., Pacchiarotti, A., Bonmassar, E., Zambruno, G., & D’Atri, S. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20567 · Cited by 36

Identification of temozolomide resistance factors in glioblastoma via integrative miRNA/mRNA regulatory network analysis

Hiddingh, L., Raktoe, R. S., Jeuken, J. W. M., Hulleman, E., Noske, D. P., Kaspers, G. J. L., Vandertop, W. P., Wesseling, P., & Wurdinger, T. D. (2014) · Scientific Reports · doi:10.1038/srep05260 · Cited by 35

GADD45A plays a protective role against temozolomide treatment in glioblastoma cells

Wang, H.-H., Chang, T., Lin, W.-C., Wei, K., & Shin, J.-W. (2017) · Scientific Reports · doi:10.1038/s41598-017-06851-3 · Cited by 33

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas

Chiang, M., Chou, P., Wang, W., Sze, C., & Chang, N. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00043 · Cited by 34

FoxO3a induces temozolomide resistance in glioblastoma cells via the regulation of β-catenin nuclear accumulation

Xu, K., Zhang, Z., Pei, H., Wang, H., Li, L., & Xia, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.5459 · Cited by 34

Approaches to diagnose DNA mismatch repair gene defects in cancer

Peña-Dı́az, J., & Rasmussen, L. J. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.11.022 · Cited by 35

Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma

Talele, S., Zhang, W., Burgenske, D. M., Kim, M., Mohammad, A. S., Dragojevic, S., Gupta, S. K., Bindra, R. S., Sarkaria, J. N., & Elmquist, W. F. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000845 · Cited by 31

Function of high-mobility group A proteins in the DNA damage signaling for the induction of apoptosis

Fujikane, R., Komori, K., Sekiguchi, M., & Hidaka, M. (2016) · Scientific Reports · doi:10.1038/srep31714 · Cited by 31

Bifunctional DNA Alkylator 1,3-Bis(2-chloroethyl)-1-nitrosourea Activates the ATR-Chk1 Pathway Independently of the Mismatch Repair Pathway

Cui, B., Johnson, S. P., Bullock, N., Ali‐Osman, F., Bigner, D. D., & Friedman, H. S. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.053124 · Cited by 32

The DNA-Mismatch Repair Enzyme hMSH2 Modulates UV-B-Induced Cell Cycle Arrest and Apoptosis in Melanoma Cells

Seifert, M., Scherer, S. J., Edelmann, W., Böhm, M., Meineke, V., Löbrich, M., Tilgen, W., & Reichrath, J. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700941 · Cited by 30

Direct detection and quantification of abasic sites for in vivo studies of DNA damage and repair

Wang, Y., Liu, L., Wu, C., Bulgar, A., Somoza, E. A., Zhu, W., & Gerson, S. L. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.07.007 · Cited by 31

Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib

Caporali, S., Alvino, E., Lacal, P. M., Ruffini, F., Levati, L., Bonmassar, L., Scoppola, A., Marchetti, P., Mastroeni, S., Cappellini, G. C. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23052 · Cited by 29

Interpreting cell cycle effects of drugs: the case of melphalan

Lupi, M., Cappella, P., Matera, G., Natoli, C., & Ubezio, P. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0044-1 · Cited by 29

DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance

de Sousa, J. F., Serafim, R. B., de Freitas, L. M., Fontana, C. R., & Valente, V. (2019) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2019-0066 · Cited by 28

A fluorine containing bipyridine cisplatin analog is more effective than cisplatin at inducing apoptosis in cancer cell lines

Elwell, K., Hall, C., Tharkar, S., Giraud, Y., Bennett, B. L., Bae, C., & Carper, S. W. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.08.016 · Cited by 28

Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia

Ziv, S., Brenner, O. J., Amariglio, N., Smorodinsky, N. I., Galron, R., Carrion, D. V., Zhang, W., Sharma, G. G., PANDITA, R. K., Agarwal, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi324 · Cited by 28

Oncolytic viruses and DNA-repair machinery: overcoming chemoresistance of gliomas

Jiang, H., Alonso, M. M., Gomez‐Manzano, C., Piao, Y., & Fueyo-Margareto, J. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.11.1585 · Cited by 28

Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer

Song, X., Xie, L., Wang, X., Zeng, Q., Chen, T. C., Wang, W., & Song, X. (2016) · Scientific Reports · doi:10.1038/srep22762 · Cited by 27

Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?

Elshazly, A. M., & Gewirtz, D. A. (2023) · Cells · doi:10.3390/cells12040535 · Cited by 26

Ependymoma stem cells are highly sensitive to temozolomide in vitro and in orthotopic models

Meco, D., Servidei, T., Lamorte, G., Binda, E., Arena, V., & Riccardi, R. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou008 · Cited by 26

High Expression of the Mismatch Repair Protein MSH6 Is Associated With Poor Patient Survival in Melanoma

Alvino, E., Passarelli, F., Cannavò, E., Fortes, C., Mastroeni, S., Caporali, S., Jiricny, J., Cappellini, G. C. A., Scoppola, A., Marchetti, P., et al. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcpcx2d9yulbblg · Cited by 26

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma

Ganesa, S., Sule, A. D., Sundaram, R. K., & Bindra, R. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-09614-x · Cited by 25

Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells

Cui, B., Johnson, S. P., Bullock, N., Ali‐Osman, F., Bigner, D. D., & Friedman, H. S. (2010) · Journal of Biomedical Research · doi:10.1016/s1674-8301(10)60057-7 · Cited by 26

Targeting of EGFR increase anti-cancer effects of arsenic trioxide: Promising treatment for glioblastoma multiform

Mesbahi, Y., Zekri, A., Ahmadian, S., Alimoghaddam, K., Ghavamzadeh, A., & Ghaffari, S. H. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.12.041 · Cited by 22

Antitumor effect of fibrin glue containing temozolomide against malignant glioma

Anai, S., Hide, T., Takezaki, T., Kuroda, J., Shinojima, N., Makino, K., Nakamura, H., Yano, S., & Kuratsu, J. (2014) · Cancer Science · doi:10.1111/cas.12397 · Cited by 21

Ionizing radiation induces neuronal differentiation of Neuro-2a cells via PI3-kinase and p53-dependent pathways

Eom, H. S., Park, H., Jo, S., Kim, Y., Moon, C., & Jung, U. (2015) · International Journal of Radiation Biology · doi:10.3109/09553002.2015.1029595 · Cited by 20

Squalene Inhibits ATM-Dependent Signaling in γIR-Induced DNA Damage Response through Induction of Wip1 Phosphatase

Tatewaki, N., Konishi, T., Nakajima, Y., Nishida, M., Saito, M., Eitsuka, T., Sakamaki, T., Ikekawa, N., & Nishida, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147570 · Cited by 21

Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia

Caporaso, P., Turriziani, M., Venditti, A., Marchesi, F., Buccisano, F., Tirindelli, M. C., Alvino, E., Garbin, A., Tortorelli, G., Toppo, L., et al. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.03.016 · Cited by 19

ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study

Romano, F. J., Guadagno, E., Solari, D., Borrelli, G., Pignatiello, S., Cappabianca, P., & De, M. D. B. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26699 · Cited by 18

The Role of Mismatch Repair in Glioblastoma Multiforme Treatment Response and Resistance

Leelatian, N., Hong, C. S., & Bindra, R. S. (2021) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2020.12.009 · Cited by 17

Dynamic structural remodeling of LINC01956 enhances temozolomide resistance in MGMT -methylated glioblastoma

Liao, X., Zhang, S., Li, X., Qian, W., Li, M., Chen, S., Wu, X., Yu, X., Li, Z., Tang, M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ado1573 · Cited by 18

Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer

Qin, S., Kitty, I., Hao, Y., Zhao, F., & Kim, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210212 · Cited by 14

Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment

Rozpędek‐Kamińska, W., Pytel, D., Nowak-Zduńczyk, A., Lewko, D., Wojtczak, R., Diehl, J. A., & Majsterek, I. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180117102233 · Cited by 15

A novel protein, MAPO1, that functions in apoptosis triggered by O6-methylguanine mispair in DNA

Komori, K., Takagi, Y., Sanada, M., Lim, T.-H., Nakatsu, Y., Tsuzuki, T., Sekiguchi, M., & Hidaka, M. (2009) · Oncogene · doi:10.1038/onc.2008.462 · Cited by 15

A CRM1‐dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization

Brieger, A., Adam, R., Passmann, S., Plotz, G., Zeuzem, S., & Trojan, J. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20832 · Cited by 14

Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide

Eich, M., Roos, W. P., Nikolova, T., & Kaina, B. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0136 · Cited by 124

Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR–Chk1 pathway

Yamane, K., Taylor, K., & Kinsella, T. J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.030 · Cited by 48

CHK1 and CHK2 are differentially involved in mismatch repair–mediated 6-thioguanine-induced cell cycle checkpoint responses

Yan, T., Desai, A. B., Jacobberger, J. W., Sramkoski, R. M., Loh, T., & Kinsella, T. J. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1147.3.9 · Cited by 42

The p38 Mitogen-Activated Protein Kinase Pathway Links the DNA Mismatch Repair System to the G 2 Checkpoint and to Resistance to Chemotherapeutic DNA-Methylating Agents

Hirose, Y., Katayama, M., Stokoe, D., Haas-Kogan, D. A., Berger, M. S., & Pieper, R. O. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8306-8315.2003 · Cited by 122

Early Chk1 Phosphorylation Is Driven by Temozolomide-Induced, DNA Double Strand Break- and Mismatch Repair-Independent DNA Damage

Ito, M., Ohba, S., Gaensler, K. M. L., Ronen, S. M., Mukherjee, J., & Pieper, R. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062351 · Cited by 31